Theme: Advanced Regulatory Compliance in Pharmacovigilance operations and innovations

Pharmacovigilance 2017

Pharmacovigilance 2017

Sessions/Tracks

Conference Series LLC solicts your gracious presence at the upcoming 9th International Conference and Exhibition on Pharmacovigilance & Drug Safety scheduled to happen during July 17-19, 2017 in Munich, Germany focussing on the advancements in emerging research and technologies in pharmacovigilance, clinical trials and risk management.

The field of Pharmacovigilance is growing rapidly and its development is making tremendous impacts in medical sciences and pharmaceuticals. 9th International Conference and Exhibition on Pharmacovigilance & Drug Safety emphasizes on how the importance and significance can be gauged by the fact that it has made huge advancements over the course of time and is continuing to influence various sectors.

Theme:  “Advanced Regulatory Compliance in Pharmacovigilance Operations and Innovations”

Track 1: Pre-Clinical and Clinical Trials

The global clinical trials market has been estimated to reach USD 14.2 billion in 2016 and is projected to reach around USD 22 billion by the year 2021, growing at a CAGR (compounded annual growth rate) of 7.5%, during the forecast period 2016 to 2021. Clinical trial is a part of clinical research that follows a regulated protocol. Clinical trials are primarily performed to get data on safety and efficacy of the new developed drug. Clinical trial data is mandatory for further approval of the drug and to bring it into the market.

Related Conferences:

3rd International Conference on Advanced Clinical Research and Clinical trials September 20-21, 2017 Dublin, Ireland; 5th Annual International; Conference on Pharmacology and Pharmaceutical Sciences September 25-26, 2017 Singapore; 11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry Feburary 27- March, 2017  Amsterdam, Netherlands; 7th European Biosimilars Congress May 15-17, 2017  Munich, Germany; 8th Global Pharmacovigilance and Drug Safety Summit  July 10-11, 2017  Jakarta, Indonesia; 8th World Congress on Pharmacology, August 07-09, 2017, Paris, France; 6th World Pharmacists and Clinical Pharmacy Annula Congress May 22-24, 2017 Chicago, USA; 8th Annual Pharmaceutical Analysis Congress  September 25-27,2017 Vienna, Austria

Related Associations or Socities:

Society for Clinical Trials (SCT), Association of Clinical Research, The Society of Clinical Research Associates, Association of Clinical Research Organization, Clinical Research Society, Indian Society for Clinical Organization Research (ISCR)

 

Track 2Adverse Drug Reactions

Adverse drug reactions can be considered a form of toxicity or enhanced drug effects that occur during appropriate use (eg, when drug metabolism is temporarily inhibited by a disorder or another drug). In the US, 3 to 7% of all hospitalizations are due to adverse drug reactions. ADRs occur during 10 to 20% of hospitalizations; about 10 to 20% of these ADRs are severe. Incidence of death due to ADRs is unknown; suggested rates of 0.5 to 0.9% may be falsely high because many of the patients included had serious and complex disorders. Incidence and severity of adverse drug reactions vary by patient characteristics (eg, age, sex, ethnicity, coexisting disorders, genetic or geographic factors) and by drug factors (eg, type of drug, administration route, treatment duration, dosage, bioavailability). Incidence is higher with advanced age and polypharmacy. 

Related Conferences:

5th International Conference and Exhibition on Pharmacology and Ethnopharmacology March 23-25, 2017 Orlando,USA; 5th Annual International; Conference on Pharmacology and Pharmaceutical Sciences September 25-26, 2017 Singapore; 11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry Feburary 27- March, 2017  Amsterdam, Netherlands; 7th European Biosimilars Congress May 15-17, 2017  Munich, Germany; 8th Global Pharmacovigilance and Drug Safety Summit July 10-11, 2017  Jakarta, Indonesia; 8th World Congress on Pharmacology, August 07-09, 2017, Paris, France; 3rd International Conference on Advanced Clinical Research and Clinical trials September 20-21 Dublin, Ireland; 6th World Pharmacists and Clinical Pharmacy Annula Congress May 22-24, 2017 Chicago, USA; 8th Annual Pharmaceutical Analysis Congress  September 25-27,2017 Vienna, Austria

Related Associations or Socities:

American Association of Pharmaceutical Scientists, Indian Pharmaceutical Association, Association of Clinical Research, The International Society of Pharmacovigilance, Canadian Society of Pharmaceutical Sciences (CSPS), Association of Clinical Reserach Organization (ACRO)

 

Track 3: Clinical Trials on Various Disorders

Clinical Trials on various diseases include Clinical Trials in long chronic diseases like AIDS, Benign and Malignant Tumours,Cardiovascular diseases, Diabetes, Clinical Trials on Monoclonal and Polyclonal Antibodies, Neurological, Physiological and Psychological Disorders

Related Conferences:

8th Annual Pharmaceutical Analysis Congress  September 25-27,2017 Vienna, Austria; 5th Annual International; Conference on Pharmacology and Pharmaceutical Sciences September 25-26, 2017 Singapore; 11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry Feburary 27- March, 2017  Amsterdam, Netherlands; 7th European Biosimilars Congress May 15-17, 2017  Munich, Germany; 8th Global Pharmacovigilance and Drug Safety Summit July 10-11, 2017  Jakarta, Indonesia; 8th World Congress on Pharmacology, August 07-09, 2017, Paris, France; 3rd International Conference on Advanced Clinical Research and Clinical trials September 20-21 Dublin, Ireland; 6th World Pharmacists and Clinical Pharmacy Annula Congress May 22-24, 2017 Chicago, USA

Related Associations or Socities:

The Society of Clinical Research Associates (SOCRA), Clinical Research Society, Society for Clinical Trials (SCT), Associates of Clinical Research, Association of British Pharmaceutical Industry, Canadian Society of Pharmaceutical Sciences (CSPS)

 

Track 4: Pharmacovigilance and Risk Management

Pharmacovigilance and Risk Management comprises set of pharmacovigilance activities and interventions designed to identify, characterise, prevent or minimise risks relating to medicinal and therapeutic products including the assessment of the effectiveness of their clinical interventions.and combination therapies. Drug industry need to promote companies in pharmacovigilance practice to use information technology and to review softwares used in pharmacovigilance and clinical trials. Monitoring unlicensed, off labels and orphan drugs is major task in risk management. Many experts from different pharmacovigilance CRO's , pharmacovigilance service providers and industrial delegates are participating in this conference to share their knowledge and discuss about the new updates.

Related Conferences:

5th International Conference and Exhibition on Pharmacology and Ethnopharmacology March 23-25, 2017 Orlando,USA; 5th Annual International; Conference on Pharmacology and Pharmaceutical Sciences September 25-26, 2017 Singapore; 11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry Feburary 27- March, 2017  Amsterdam, Netherlands; 7th European Biosimilars Congress May 15-17, 2017  Munich, Germany; 8th Global Pharmacovigilance and Drug Safety Summit July 10-11, 2017  Jakarta, Indonesia; 8th World Congress on Pharmacology, August 07-09, 2017, Paris, France; 3rd International Conference on Advanced Clinical Research and Clinical trials September 20-21 Dublin, Ireland; 6th World Pharmacists and Clinical Pharmacy Annula Congress May 22-24, 2017 Chicago, USA; 8th Annual Pharmaceutical Analysis Congress  September 25-27,2017 Vienna, Austria

Related Associations or Socities:

The International Society of Pharmacovigilance (ISOP), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Association of Clinical Research Organization (ACRO), Indian Pharmaceutical Association, Association of Clinical Reserach

 

Track 5: Drug Safety

Drug Safety heavily focuses on adverse drug reactions which are defined as any response to a drug which is noxious and unintended, including lack of efficacy. Medication errors such as overdose, and misuse and abuse of a drug as well as drug exposure during pregnancy and breastfeeding, are also of interest, even without an adverse event, because they may result in an adverse drug reaction.

Information received from patients and healthcare providers via pharmacovigilance agreements (PVAs), as well as other sources such as the medical literature, plays a critical role in providing the data necessary for pharmacovigilance to take place. Ultimately, drug safety is concerned with identifying the hazards associated with pharmaceutical products and with minimizing the risk of any harm that may come to patients. Companies must conduct a comprehensive drug safety and pharmacovigilance audit to assess their compliance with worldwide laws, regulations, and guidance.

Related Conferences:

5th International Conference and Exhibition on Pharmacology and Ethnopharmacology March 23-25, 2017 Orlando,USA; 5th Annual International; Conference on Pharmacology and Pharmaceutical Sciences September 25-26, 2017 Singapore; 11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry Feburary 27- March, 2017  Amsterdam, Netherlands; 7th European Biosimilars Congress May 15-17, 2017  Munich, Germany; 8th Global Pharmacovigilance and Drug Safety Summit July 10-11, 2017  Jakarta, Indonesia; 8th World Congress on Pharmacology, August 07-09, 2017, Paris, France; 3rd International Conference on Advanced Clinical Research and Clinical trials September 20-21 Dublin, Ireland; 6th World Pharmacists and Clinical Pharmacy Annula Congress May 22-24, 2017 Chicago, USA; 8th Annual Pharmaceutical Analysis Congress  September 25-27,2017 Vienna, Austria

Related Associations or Socities:

Society for Clinical Trials (SCT)Association of Clinical ResearchThe Society of Clinical Research AssociatesAssociation of Clinical Research OrganizationClinical Research SocietyIndian Society for Clinical Organization Research (ISCR)

 

Track 6: Good Pharmacovigilance Practice

The role of Good Pharmacovigilance Practice and Pharmacoepidemiology in Risk Management is mainly to increase the probability of beneficial effects of a drug in a population than the probability of adverse effects and to maintain the Good Reporting Practices by avoiding the major problems in risk management. Also it is important to concentrate on Signal investigation by gathering the information on new or unknown drug effects that is potentially caused by a medicine and that finally should lead to ensuring safety. The pharmacovigilance and clinical trials services providing companies should have the Pharmacovigilance certification .

Related Conferences:

8th Global Pharmacovigilance and Drug Safety Summit July 10-11, 2017  Jakarta, Indonesia; 5th Annual International; Conference on Pharmacology and Pharmaceutical Sciences September 25-26, 2017 Singapore; 11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry Feburary 27- March, 2017  Amsterdam, Netherlands; 7th European Biosimilars Congress May 15-17, 2017  Munich, Germany;  8th World Congress on Pharmacology, August 07-09, 2017, Paris, France; 3rd International Conference on Advanced Clinical Research and Clinical trials September 20-21 Dublin, Ireland; 6th World Pharmacists and Clinical Pharmacy Annula Congress May 22-24, 2017 Chicago, USA; 8th Annual Pharmaceutical Analysis Congress  September 25-27,2017 Vienna, Austria

Related Associations or Socities:

American Association of Pharmaceutical ScientistsIndian Pharmaceutical AssociationAssociation of Clinical ResearchThe International Society of PharmacovigilanceCanadian Society of Pharmaceutical Sciences (CSPS)Association of Clinical Reserach Organization (ACRO)

 

Track 7: Data Quality Management and Analysis

Good data quality management in pharmacovigilance can be relied only on information gathered from the collection of individual case safety reports and other pharmacoepidemiological data. Quality management consists of quality planning, quality control, quality assurance and quality improvements. The pharmacovigilance data processing cycle starts with data collection and, in computerised systems, data entry; the next step is data storage and maintenance; followed by data selection, retrieval and manipulation. The resulting data output is analysed and assessed. Finally, conclusions are drawn and decisions are made. The quality of a pharmacovigilance data system can be defined as a measure of excellence or a state of being free from defects, deficiencies and significant variations and the  data quality management includes all the activities that organizations use to direct, control and coordinate the quality of data.

Related Conferences:

8th Annual Pharmaceutical Analysis Congress  September 25-27,2017 Vienna, Austria; 8th World Congress on Pharmacology, August 07-09, 2017, Paris, France; 5th Annual International; Conference on Pharmacology and Pharmaceutical Sciences September 25-26, 2017 Singapore; 11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry Feburary 27- March, 2017  Amsterdam, Netherlands; 7th European Biosimilars Congress May 15-17, 2017  Munich, Germany; 8th Global Pharmacovigilance and Drug Safety Summit April 17-18, 2017, Bali, Indonesia; ; 3rd International Conference on Advanced Clinical Research and Clinical trials September 20-21 Dublin, Ireland; 6th World Pharmacists and Clinical Pharmacy Annula Congress May 22-24, 2017 Chicago, USA 

Related Associations or Socities:

Pharmaceutical Information and Pharmacovgilance Association (PIPA)American Association of Pharmaceutical; ScientistsAmerican Society of Pharmacognosy Association of Clinical Reserach Organization (ACRO)Society for Clinical Trials (SCT)Association of Clinical Research

 

Track 8: Pharmacovigilance Significance & Scope

Concept of Pharmacovigilance and its Significance enhances the impact of pharmacovigilance on patient welfare and public health and to know what is pharmacovigilance. This track gives a brief discussion on Pharmacovigilance role in healthcare system. Pharmacovigilance legislation gives an outlook on the rules and laws to follow in Pharmacovigilance practice. The Role of pharma industries in the improvement of pharmacovigilance system is very crucial to maintain the safety data, Detection and Evaluation of drug safety signals through manual and medical devices reporting. Pharmacovigilance scope also deals as Ecopharmacovigilance (EPV), pharmacoenvironmentology and pharmacovigilance in herbal medicines.

Related Conferences:

11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry Feburary 27- March, 2017  Amsterdam, Netherlands; 5th International Conference and Exhibition on Pharmacology and Ethnopharmacology March 23-25, 2017 Orlando,USA; 7th European Biosimilars Congress May 15-17, 2017  Munich, Germany; 8th Global Pharmacovigilance and Drug Safety Summit July 10-11, 2017  Jakarta, Indonesia; 8th World Congress on Pharmacology, August 07-09, 2017, Paris, France; 3rd International Conference on Advanced Clinical Research and Clinical trials September 20-21 Dublin, Ireland; 6th World Pharmacists and Clinical Pharmacy Annula Congress May 22-24, 2017 Chicago, USA; 8th Annual Pharmaceutical Analysis Congress  September 25-27,2017 Vienna, Austria 

Related Associations or Socities:

American Association of Pharmaceutical ScientistsIndian Pharmaceutical AssociationAssociation of Clinical ResearchThe International Society of PharmacovigilanceCanadian Society of Pharmaceutical Sciences (CSPS)Association of Clinical Reserach Organization (ACRO)

 

Track 9: Diversity in Industrial Clinical Trials and Clinical Research

The clinical trial industry is constantly evolving with diversified clinical research technologies and new clinical studies are being launched at an ever-growing pace. Clinical trials have always been a vital part of the medicine development process, as they provide clinical data on the best ways for treating pathological disorders and diseases. The importance of diversity in industrial clinical trials and clinical research is to ensure that industrial clinical trials are doing due diligence and being as strategic as possible in their results.This diversity makes us to better understand the unmet medical needs of patients.

Related Conferences:

5th International Conference and Exhibition on Pharmacology and Ethnopharmacology March 23-25, 2017 Orlando,USA; 5th Annual International; Conference on Pharmacology and Pharmaceutical Sciences September 25-26, 2017 Singapore; 11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry Feburary 27- March, 2017  Amsterdam, Netherlands; 7th European Biosimilars Congress May 15-17, 2017  Munich, Germany; 8th Global Pharmacovigilance and Drug Safety Summit July 10-11, 2017  Jakarta, Indonesia; 8th World Congress on Pharmacology, August 07-09, 2017, Paris, France; 3rd International Conference on Advanced Clinical Research and Clinical trials September 20-21 Dublin, Ireland; 6th World Pharmacists and Clinical Pharmacy Annula Congress May 22-24, 2017 Chicago, USA; 8th Annual Pharmaceutical Analysis Congress  September 25-27,2017 Vienna, Austria

Related Associations or Socities:

Society for Clinical Trials (SCT)Association of Clinical ResearchThe Society of Clinical Research AssociatesAssociation of Clinical Research OrganizationClinical Research SocietyIndian Society for Clinical Organization Research (ISCR)

 

Track 10: Clinical Research and Statistics

In Clinical Research, Statistics plays a prominent role in regulatory submissions. Statistical analysis of  Pharmacovigilance can be achieved by several guidelines mainly ICH guidelines. Adverse Drug Reactions reports can also be considered for the regulatory submission.

Related Conferences:

6th World Pharmacists and Clinical Pharmacy Annula Congress May 22-24, 2017 Chicago, USA; 5th International Conference and Exhibition on Pharmacology and Ethnopharmacology March 23-25, 2017 Orlando,USA; 5th Annual International; Conference on Pharmacology and Pharmaceutical Sciences September 25-26, 2017 Singapore; 11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry Feburary 27- March, 2017  Amsterdam, Netherlands; 7th European Biosimilars Congress May 15-17, 2017  Munich, Germany; 8th Global Pharmacovigilance and Drug Safety Summit July 10-11, 2017  Jakarta, Indonesia; 8th World Congress on Pharmacology, August 07-09, 2017, Paris, France; 3rd International Conference on Advanced Clinical Research and Clinical trials September 20-21 Dublin, Ireland; 8th Annual Pharmaceutical Analysis Congress  September 25-27,2017 Vienna, Austria

Related Associations or Socities:

American Association of Pharmaceutical ScientistsIndian Pharmaceutical AssociationAssociation of Clinical ResearchThe International Society of PharmacovigilanceCanadian Society of Pharmaceutical Sciences (CSPS)Association of Clinical Reserach Organization (ACRO)

 

Track 11: Case Report in Clinical Trials

Case Report in Clinical Trials plays a key role in Clinical Research. Case reports may be on unexpected association between diseases, disorders or symptoms. An unexpected event in the course of observing, treating a patient,possibilities of  pathogenesis of a disease or an adverse effect.Unique or rare salient features of a disease or therapeutic approaches or a notable variation of the anatomical structures.

Related Conferences:

3rd International Conference on Advanced Clinical Research and Clinical trials September 20-21 Dublin, Ireland; 6th World Pharmacists and Clinical Pharmacy Annula Congress May 22-24, 2017 Chicago, USA;5th International Conference and Exhibition on Pharmacology and Ethnopharmacology March 23-25, 2017 Orlando,USA; 5th Annual International; Conference on Pharmacology and Pharmaceutical Sciences September 25-26, 2017 Singapore; 11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry Feburary 27- March, 2017  Amsterdam, Netherlands; 7th European Biosimilars Congress May 15-17, 2017  Munich, Germany; 8th Global Pharmacovigilance and Drug Safety Summit July 10-11, 2017  Jakarta, Indonesia; 8th World Congress on Pharmacology, August 07-09, 2017, Paris, France; 8th Annual Pharmaceutical Analysis Congress  September 25-27,2017 Vienna, Austria

Related Associations or Socities:

The Society of Clinical Research Associates (SOCRA)Clinical Research SocietySociety for Clinical Trials (SCT)Associates of Clinical ResearchAssociation of British Pharmaceutical IndustryCanadian Society of Pharmaceutical Sciences (CSPS)

 

Track 12: Pharmacokinetics and Pharmacodynamics

Drugs may undergo, Pharmacokinetics and Pharmacodynamics and toxicity testing through animal testing. The phenomena of drug absorption, distribution, metabolism, and excretion and pharmacokinetic principles enhances the safety and efficacy of  therapeutic management of pharmaceutical drugs in an individual patient drug therapy. Pharmacodynamic Interactions, Drug and substance abuse, Drug-drug interactions and clinical drug intervention data allows research scientist estimate a safe starting dose of the drug for clinical trials in humans.

Related Conferences:

7th European Biosimilars Congress May 15-17, 2017  Munich, Germany; 8th Global Pharmacovigilance and Drug Safety Summit July 10-11, 2017  Jakarta, Indonesia5th International Conference and Exhibition on Pharmacology and Ethnopharmacology March 23-25, 2017 Orlando,USA; 5th Annual International; Conference on Pharmacology and Pharmaceutical Sciences September 25-26, 2017 Singapore; 11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry Feburary 27- March, 2017  Amsterdam, Netherlands;  8th World Congress on Pharmacology, August 07-09, 2017, Paris, France; 3rd International Conference on Advanced Clinical Research and Clinical trials September 20-21 Dublin, Ireland; 6th World Pharmacists and Clinical Pharmacy Annula Congress May 22-24, 2017 Chicago, USA; 8th Annual Pharmaceutical Analysis Congress  September 25-27,2017 Vienna, Austria

Related Associations or Socities:

Association of British Pharmaceutical IndustryCanadian Society of Pharmaceutical Sciences (CSPS)Pharmaceutical Information and Pharmacovgilance Association (PIPA)American Association of Pharmaceutical; ScientistsAmerican Society of Pharmacognosy 

 

Track 13: Clinical Data Base Management

There is an advantage in centralising all safety data, clinical data, analysis and reporting with one provider. Pharmacovigilance Software tool provides comprehensive analysis of adverse events arising from the use of Pharmaceutical products (Medicinal Product, Medical Device, Vaccines, Non-Drug Therapy and Veterinary Medicinal Product). The drug safety database allows the risk- benefit analysis of medicinal products taking into account new and emerging information, in the context of cumulative information. Pharmacovigilance since beginning has been a compliance driven activity, wherein your regulatory compliance determines company’s risk assessment scores. A drug safety database offers scheduling of alerts for expedited cases, follow-up cases and PSUR/PADER reports submission to meet regulatory timeline compliance.

Related Conferences:

9th Annual European Pharma Congress July 10-12, 2017 Madrid, Spain; 11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry Feburary 27- March, 2017  Amsterdam, Netherlands; 7th European Biosimilars Congress May 15-17, 2017  Munich, Germany; 8th Global Pharmacovigilance and Drug Safety Summit July 10-11, 2017  Jakarta, Indonesia; 8th World Congress on Pharmacology, August 07-09, 2017, Paris, France; 3rd International Conference on Advanced Clinical Research and Clinical trials September 20-21 Dublin, Ireland; 6th World Pharmacists and Clinical Pharmacy Annula Congress May 22-24, 2017 Chicago, USA; 8th Annual Pharmaceutical Analysis Congress  September 25-27,2017 Vienna, Austria

Related Associations or Socities:

The Society of Clinical Research Associates (SOCRA)Clinical Research SocietySociety for Clinical Trials (SCT)Associates of Clinical ResearchAssociation of British Pharmaceutical IndustryCanadian Society of Pharmaceutical Sciences (CSPS)

 

Track 14: PV Consulting’s and Business opportunity

Due to the changing resources necessary to fulfil the regulatory requirements, some companies also choose to outsource or out task regulatory affairs to external service providers. Regulatory Affairs department is constantly evolving and growing and is the one which is least impacted during the Acquisition and Merger, and also during recession..The global pharmacovigilance market and Business opportunity bwas valued at USD 2,408.0 million in 2013 and is expected to grow at a CAGR of 12.6% during the forecast period. Phase III clinical trials market was the second largest and was valued at over USD 750.0 million in 2013.

Related Conferences:

11th International Conference on Pharmacoepidemiology and Clinical Research  July 06-08, 2017 Kuala Lumpur, Malaysia ; 11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry Feburary 27- March, 2017  Amsterdam, Netherlands; 7th European Biosimilars Congress May 15-17, 2017  Munich, Germany; 8th Global Pharmacovigilance and Drug Safety Summit July 10-11, 2017  Jakarta, Indonesia; 8th World Congress on Pharmacology, August 07-09, 2017, Paris, France; 3rd International Conference on Advanced Clinical Research and Clinical trials September 20-21 Dublin, Ireland; 6th World Pharmacists and Clinical Pharmacy Annula Congress May 22-24, 2017 Chicago, USA; 

Related Associations or Socities:

Association of British Pharmaceutical Industry, Canadian Society of Pharmaceutical Sciences (CSPS), Pharmaceutical Information and Pharmacovgilance Association (PIPA), American Association of Pharmaceutical; Scientists, American Society of Pharmacognosy ; 5th International Conference and Exhibition on Pharmacology and Ethnopharmacology March 23-25, 2017 Orlando,USA

 

Track 15: Regulatory Affairs

Regulatory Affairs for clinical trials is the major part in the clinical trials approaches. Every clinical trial must be analysed according to the Regulatory Affairs Guidelines. There are several Regulatory Affairs departments depending upon the countries within evergrowing pace of companies. Global Harmonization in standards has led to consistent approach in regulatory submissions and hence its review.

Related Conferences:

5th International Conference and Exhibition on Pharmacology and Ethnopharmacology March 23-25, 2017 Orlando,USA; 5th Annual International; Conference on Pharmacology and Pharmaceutical Sciences September 25-26, 2017 Singapore; 11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry Feburary 27- March, 2017  Amsterdam, Netherlands; 7th European Biosimilars Congress May 15-17, 2017  Munich, Germany; 8th Global Pharmacovigilance and Drug Safety Summit July 10-11, 2017  Jakarta, Indonesia; 8th World Congress on Pharmacology, August 07-09, 2017, Paris, France; 3rd International Conference on Advanced Clinical Research and Clinical trials September 20-21 Dublin, Ireland; 6th World Pharmacists and Clinical Pharmacy Annula Congress May 22-24, 2017 Chicago, USA; 8th Annual Pharmaceutical Analysis Congress  September 25-27,2017 Vienna, Austria

Related Associations or Socities: 

The International Society of Pharmacovigilance (ISOP)Pharmaceutical Information and Pharmacovigilance Association (PIPA)Association of Clinical Research Organization (ACRO)Indian Pharmaceutical AssociationAssociation of Clinical Reserach

 

Track 16: Growth strategies in Pharma

Strategies for Growth in Pharma Environment track mainly focused in Strategic development towards FDA approval and Post market product Surveillances. The updates and advances in Pharmacovigilance Regulation system are discussed under Advances in Changing Pharmacovigilance Regulation System track.

Related Conferences:

 5th Annual International; Conference on Pharmacology and Pharmaceutical Sciences September 25-26, 2017 Singapore; 11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry Feburary 27- March, 2017  Amsterdam, Netherlands; 7th European Biosimilars Congress May 15-17, 2017  Munich, Germany; 8th Global Pharmacovigilance and Drug Safety Summit July 10-11, 2017  Jakarta, Indonesia; 8th World Congress on Pharmacology, August 07-09, 2017, Paris, France; 3rd International Conference on Advanced Clinical Research and Clinical trials September 20-21 Dublin, Ireland; 6th World Pharmacists and Clinical Pharmacy Annula Congress May 22-24, 2017 Chicago, USA; 8th Annual Pharmaceutical Analysis Congress  September 25-27,2017 Vienna, Austria; 8th World Congress on Pharmacology and Toxicology July 24-26, 2017 Melbourne, Australia.

Related Associations or Socities:

The Society of Clinical Research Associates (SOCRA)Clinical Research SocietySociety for Clinical Trials (SCT)Associates of Clinical ResearchAssociation of British Pharmaceutical IndustryCanadian Society of Pharmaceutical Sciences (CSPS)

 

Track 17Pharmacy Practices and its Challenges

Pharmacy practice is the field of pharmacy which involves developing the professional roles of pharmacists. It includes Disease-state management, Clinical drug interventions, Pharmacy professional development and pharmaceutical care, pharmaceutical compounding and health psychology, patient care, drug abuse prevention, prevention of drug interactions or minimisation of adverse events and drug incompatibility and community pharmacy.

Related Conferences:

7th European Biosimilars Congress May 15-17, 2017  Munich, Germany; 8th Global Pharmacovigilance and Drug Safety Summit July 10-11, 2017  Jakarta, Indonesia; 5th International Conference and Exhibition on Pharmacology and Ethnopharmacology March 23-25, 2017 Orlando,USA; 5th Annual International; Conference on Pharmacology and Pharmaceutical Sciences September 25-26, 2017 Singapore; 11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry Feburary 27- March, 2017  Amsterdam, Netherlands;  8th World Congress on Pharmacology, August 07-09, 2017, Paris, France; 3rd International Conference on Advanced Clinical Research and Clinical trials September 20-21 Dublin, Ireland; 6th World Pharmacists and Clinical Pharmacy Annula Congress May 22-24, 2017 Chicago, USA; 8th Annual Pharmaceutical Analysis Congress  September 25-27,2017 Vienna, Austria

Related Associations or Socities:

Society for Clinical Trials (SCT)Association of Clinical ResearchThe Society of Clinical Research AssociatesAssociation of Clinical Research OrganizationClinical Research SocietyIndian Society for Clinical Organization Research (ISCR)





About the Conference

Conference Series LLC is organizing splendorous Pharmaceutical conferences welcomes you to attend the 9th International Conference and Exhibition on Pharmacovigilance & Drug Safety  to be held during July 17-19, 2017 in Munich, Germany. It focuses on the advancements in Pharmacovigilance, Risk Management, Drug Safety.

The field of Pharmacovigilance is growing rapidly and its development is making tremendous impacts in medical sciences and pharmaceuticals. 9th International Conference and Exhibition on Pharmacovigilance & Drug Safety  emphasizes on how the importance and significance can be gauged by the fact that it has made huge advancements over the course of time and is continuing to influence various sectors. 

Why to attend???

With members from around the world focused on learning about Pharmacovigilance and its advances; this is your best opportunity to reach the largest assemblage of participants from the Pharmacovigilance community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, and receive named recognition at this 3-days event. World-Renowned Speakers, the most recent techniques, developments, and the newest updates in Pharmacovigilance are Hallmarks of this Conference.

Target Audience:

  • Pharmacovigilance Students, Scientists
  • Pharmacovigilance Researchers
  • Pharmacovigilance Faculty
  • Medical Colleges
  • Pharmacovigilance Associations and Societies
  • Business Entrepreneurs
  • Training Institutes
  • Software Developing Companies
  • Manufacturing Medical Devices Companies
  • Data Management Companies




Market Analysis

Summary: Pharmacovigilance 2017 welcomes Attendees, Presenters, and Exhibitors from all over the world to Munich, Germany. We are delighted to invite you all to attend and register for the “9th International Conference and Exhibition on Pharmacovigilance & Drug Safety” which is going to be held during July 17-19, 2017 in Munich, Germany. The Organizing Committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Pharmacovigilance 2017, where you will be sure to have a meaningful experience with scholars from around the world. All the members of Pharmacovigilance 2017 Organizing Committee will look forward to meet you at Munich, Germany.

For more details please visit- http://pharmacovigilance.pharmaceuticalconferences.com/

Importance and Scope: Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other medicine-related problem. The main purpose of pharmacovigilance is to improve the patient's safety and enhance his care in terms of the use of medicines, including paramedical interventions. Pharmacovigilance also supports public health programs by providing reliable information for the efficient assessment of the risk-benefit profile of medicines, contribute to the assessment of benefits, uses, side effects, harm, effectiveness and risk of medicines, encouraging the safe, rational and more effective (including cost-effective) use of various medicines. Promote education, understanding and clinical training in Pharmacovigilance and its effective availability to the public.

Why Munich, Germany?

The Global Pharmacovigilance Market is expected to reach USD 5.51 billion by 2020. Increasing incidence rates of adverse drug reaction (ADR) and the introduction of stringent drug safety regulations are some key drivers of this market. ADR is responsible for approximately 5% of the hospitalization in developed countries annually, and this is expected to boost usage rates over the next six years. Pharmacovigilance has witnessed a significant rise in usage rates in the recent times owing to growing global geriatric population triggering a growth in demand for new drug development. Additionally, health regulatory authorities such as the U.S. FDA and EMEA (European Medicines Agency) are now emphasizing on electronic submission of data which is also expected to drive the pharmacovigilance market.


The global pharmacovigilance market is segmented as follows:


Pharmacovigilance Market, by Phases of Drug Development:

  • Preclinical Studies
  • Phase I
  • Phase II
  • Phase III
  • Phase IV or Post Marketing Surveillance

Pharmacovigilance Market, by Type of Methods:

  • Spontaneous Reporting
  • Intensified ADR Reporting
  • Targeted Spontaneous Reporting
  • Cohort Event Monitoring
  • EHR Mining

Pharmacovigilance Market, by Type of Service:

  • In-House
  • Contract Outsourcing

                                                        

Conference Highlights

  • Drug Safety
  • Adverse Drug Reactions
  • Pharmacovigilance Significance & Scope
  • Good Pharmacovigilance Practice
  • Pharmacovigilance and Risk Management
  • Pharmacokinetics and Pharmacodynamics
  • Pre-Clinical and Clinical Trials
  • Clinical Trials on Various Disorders
  • Diversity in Industrial Clinical Trials and Clinical Research
  • Clinical Research and Statistics
  • Case Report in Clinical Trial
  • Data Quality Management and Analysis
  • PV Data Base Managemaent
  • PV Consultings And Bussiness Opportunity
  • Regulatory Affairs
  • Growth Strategies in Pharma
  • Pharmacy Practices and its Challenges
  • Entrepreneurs Investment Meet    

Global pharmacovigilance market, by clinical trials, 2012 – 2020 (USD Million)


    fig2





Past Conference Report

Pharmacovigilance 2016

Pharmacovigilance-2016 Report

 Pharmaovigilance 2016 past Conference Report

Thanks to all of our wonderful Speakers, Conference Attendees and Sponsors; Pharmacovigilance 2016 Conference was our best ever!

The “7th International Conference and Exhibition on Pharmacovigilance”, hosted by the Conferenceseries LLC was held on August 22-24, 2016 in Fleming Hotel Wien-Westbahnhof
Neubaugürtel, 26-28,1070 Vienna, Austria. Generous response and active participation was received from the scientists, researchers and leaders from clinical, government organizations, students who made this conference as one of the most successful and productive events in 2016.

With the support and guidance of Organizing Committee Members and Editorial Board Members and astonishing presentations of all participants this prominent summit became more impressive.

Conferenceseries LLC would like to convey a great appreciation to Keynote speakers Eugenia Hong, Nathan Cummins and Alexey Skripkin.

Honourable guests and Keynote Speakers supported this event with sustainable excitement for grand success of this prominent conference. Also it is our pleasure to announce next 9th International Conference and Exhibition on Pharmacovigilance & Drug Safety which will be held during July 17-19, 2017 in Munich, Germany with the theme “Advanced Regulatory Compliance in Pharmacovigilance operations and innovations”.

We hope your favorable support will make next conference also one more grand success.

For more details about Pharmacovigilance 2017 visit

http://pharmacovigilance.pharmaceuticalconferences.com/

 


Past Reports  Gallery  



Click here to submit abstract to any of the above topics

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date July 17-19, 2017
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity
Poster Opportunity Available

Media Partners

Conferenceseries Destinations